MiRNA-based therapy for Gastic carcinoma: TAp63 inhibits gastric cell metastasis via down regulation of ZEB2, 04.58 am., 1/August/2014

MiRNA-based therapy for Gastic carcinoma: TAp63 inhibits gastric cell metastasis via down regulation of ZEB2, 04.58 am., 1/August/2014

MiRNA-based therapy for Gastic carcinoma: TAp63 inhibits gastric cell metastasis via down regulation of ZEB2, 04.58 am., 1/August/2014 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, MiRNA-based therapy for Gastic carcinoma: TAp63 inhibits gastric cell metastasis via down regulation of ZEB204.58 am., 1/August/2014,   Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation